Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.43 B1.48 B1.46 B1.39 B 5.75 B Research & development ———— — Operating income 216 M443 M282 M321 M 1.26 B Non-Operating Income, Total 1 M3 M01 M 5 M Interest expense, net of interest capitalized 75 M77 M76 M78 M 306 M Non-Operating Income, excl. Interest Expenses -75 M-77 M-76 M-78 M -306 M Unusual income/expense 1 M3 M01 M 5 M Pretax income 142 M369 M206 M244 M 961 M Equity in earnings ———— — Taxes 26 M94 M53 M60 M 233 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 116 M275 M153 M184 M 728 M Discontinued operations ———— — Net income 116 M275 M153 M184 M 728 M Dilution adjustment ———0 — Preferred dividends ———0 — Diluted net income available to common stockholders 116 M275 M153 M184 M 728 M Basic earnings per share (Basic EPS) 0.531.260.680.83 3.3 Diluted earnings per share (Diluted EPS) 0.521.240.670.82 3.25 Average basic shares outstanding 220 M219 M225.5 M227 M — Diluted shares outstanding 223 M221 M228.4 M230 M — EBITDA 335 M561 M400 M438 M 1.73 B EBIT 216 M443 M282 M321 M 1.26 B Cost of revenue 7.96 B8.61 B8.44 B8.08 B 33.09 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 119 M118 M118 M117 M 472 M